{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:15:20Z","timestamp":1788894920725,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","award":["GCU-202008420005"],"award-info":[{"award-number":["GCU-202008420005"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2020-NR049589"],"award-info":[{"award-number":["RS-2020-NR049589"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NRF-2021R1F1A1060378"],"award-info":[{"award-number":["NRF-2021R1F1A1060378"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejps.2026.107454","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:29:54Z","timestamp":1769531394000},"page":"107454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Calcitriol-mediated modulation of organic anion transporters: Insights from endogenous biomarkers and methotrexate pharmacokinetics"],"prefix":"10.1016","volume":"218","author":[{"given":"Dang-Khoa","family":"Vo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Thao-Linh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul-A","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joo","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107454_bib0001","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/psp4.12610","article-title":"Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1\/3 renal transporters","volume":"10","author":"Ahmad","year":"2021","journal-title":"CPT. Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107454_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081133","article-title":"Effects of 1?,25-dihydroxyvitamin D3 on the pharmacokinetics of procainamide and its metabolite N-acetylprocainamide, organic cation transporter substrates, in rats with PBPK modeling approach","author":"Balla","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107454_bib0003","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s001980050058","article-title":"Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men","volume":"8","author":"Barger-Lux","year":"1998","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ejps.2026.107454_bib0004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41574-019-0312-5","article-title":"New aspects of vitamin D metabolism and action \u2014 Addressing the skin as source and target","volume":"16","author":"Bikle","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejps.2026.107454_bib0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40262-024-01385-0","article-title":"Utilising endogenous biomarkers in drug development to streamline the assessment of drug\u2013Drug interactions mediated by renal transporters: a pharmaceutical industry perspective","volume":"63","author":"Choi","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107454_bib0006","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/jps.22366","article-title":"Comparative effects of doxercalciferol (1\u03b1-Hydroxyvitamin D2) versus calcitriol (1\u03b1,25-Dihydroxyvitamin D3) on the expression of transporters and enzymes in the rat In vivo","volume":"100","author":"Chow","year":"2011","journal-title":"J. Pharm. Sci"},{"key":"10.1016\/j.ejps.2026.107454_bib0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/bdd.694","article-title":"Effects of 1\u03b1,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo","volume":"31","author":"Chow","year":"2010","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.ejps.2026.107454_bib0008","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the international transporter consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107454_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111129","article-title":"Differential effects of 1?,25-dihydroxyvitamin D3 on the expressions and functions of hepatic CYP and UGT enzymes and its pharmacokinetic consequences In Vivo","author":"Doan","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107454_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106395","article-title":"Physiologically based pharmacokinetic modeling to predict OAT3-mediated drug-drug interactions of meropenem in varying stages of chronic kidney disease","volume":"183","author":"Dong","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107454_bib0011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/pr.111.004614","article-title":"Organic anion transporters and their implications in pharmacotherapy","volume":"64","author":"Emami Riedmaier","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2026.107454_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221092376","article-title":"Is there still a place for methotrexate in severe psoriatic arthritis?","volume":"14","author":"Felten","year":"2022","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.ejps.2026.107454_bib0013","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/14740338.2021.1931117","article-title":"Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency","volume":"20","author":"Galassi","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejps.2026.107454_bib0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","article-title":"Membrane transporters in drug development and as determinants of precision medicine","volume":"23","author":"Galetin","year":"2024","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.ejps.2026.107454_bib0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/endrev\/bnae009","article-title":"Consensus Statement on Vitamin D Status assessment and supplementation: whys, whens, and Hows","volume":"45","author":"Giustina","year":"2024","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejps.2026.107454_bib0016","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/toxins2082055","article-title":"Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity","author":"Hagos","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.ejps.2026.107454_bib0017","first-page":"298","article-title":"Mammalian monocarboxylate transporter 7 (MCT7\/Slc16a6) is a novel facilitative taurine transporter","author":"Higuchi","year":"2022","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ejps.2026.107454_bib0018","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cpt.3436","article-title":"Utility of biomarker-informed drug interaction evaluation in drug development and regulatory decision making","volume":"117","author":"Ishiguro","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107454_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.taap.2016.06.030","article-title":"P-gp, MRP2 and OAT1\/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate","volume":"306","author":"Jia","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107454_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152909","article-title":"Molecular toxicity of methotrexate in rheumatoid arthritis treatment: a novel perspective and therapeutic implications","volume":"461","author":"Katturajan","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.ejps.2026.107454_bib0021","doi-asserted-by":"crossref","first-page":"eadq1724","DOI":"10.1126\/sciadv.adq1724","article-title":"Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer","volume":"11","author":"Kim","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejps.2026.107454_bib0022","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/jps.24195","article-title":"Effects of 1\u03b1,25-dihydroxyvitamin D3, the natural vitamin D receptor ligand, on the pharmacokinetics of Cefdinir and Cefadroxil, organic anion transporter substrates, in rat","volume":"103","author":"Kim","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107454_bib0023","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/0006-2952(91)90160-7","article-title":"Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites: a comparative study with 1,25(OH)2D3","volume":"41","author":"Kissmeyer","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107454_bib0024","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.apsb.2022.03.009","article-title":"Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development","volume":"12","author":"Lai","year":"2022","journal-title":"Acta. Pharm. Sin. B."},{"key":"10.1016\/j.ejps.2026.107454_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106396","article-title":"Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)2D3-treated Caco-2 cells","volume":"183","author":"Lee","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107454_bib0026","doi-asserted-by":"crossref","first-page":"25461","DOI":"10.1039\/C7RA02968C","article-title":"Organic anion transporters 1 (OAT1) and OAT3 meditated the protective effect of rhein on methotrexate-induced nephrotoxicity","volume":"7","author":"Liu","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.ejps.2026.107454_bib0027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2012.11.008","article-title":"Inhibitory effect of 1\u03b1,25-dihydroxyvitamin D3 on excretion of JBP485 via organic anion transporters in rats","volume":"48","author":"Miao","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107454_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122531","article-title":"Role of vitamin D in maintaining renal epithelial barrier function in uremic conditions","author":"Mihajlovic","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107454_bib0029","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejps.2015.11.020","article-title":"Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells","volume":"82","author":"Rasmussen","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107454_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.6183","article-title":"Clinical assessment of drug transporter inhibition using biomarkers: review of the literature (2015\u20132024)","author":"Rodrigues","year":"2025","journal-title":"J. Clinic. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107454_bib0031","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00726-024-03440-3","article-title":"Taurine prevents mitochondrial dysfunction and protects mitochondria from reactive oxygen species and deuterium toxicity","volume":"57","author":"Seneff","year":"2025","journal-title":"Amino Acid."},{"key":"10.1016\/j.ejps.2026.107454_bib0032","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/dmd.117.077586","article-title":"Discovery and validation of pyridoxic acid and homovanillic acid as novel endogenous plasma biomarkers of organic anion transporter (OAT) 1 and OAT3 in Cynomolgus monkeys","volume":"46","author":"Shen","year":"2018","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107454_bib0033","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","article-title":"Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease stages 2\u20135 and on dialysis","volume":"32","author":"Shroff","year":"2017","journal-title":"Nephrol. Dialysis Transplantat."},{"key":"10.1016\/j.ejps.2026.107454_bib0034","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/cpt.3029","article-title":"Development of 4-pyridoxic acid PBPK model to support biomarker-informed evaluation of OAT1\/3 inhibition and effect of chronic kidney disease","volume":"114","author":"Tan","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107454_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115867","article-title":"Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: discovery of putative organic anion transporter biomarkers","volume":"218","author":"Thakur","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107454_bib0036","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1124\/dmd.116.071472","article-title":"Investigation of endogenous compounds applicable to drug-drug interaction studies involving the renal organic anion transporters, OAT1 and OAT3, in humans","volume":"44","author":"Tsuruya","year":"2016","journal-title":"Drug. Metab. Dispos."},{"issue":"1","key":"10.1016\/j.ejps.2026.107454_bib0037","article-title":"In vitro drug interaction studies-cytochrome P450 enzyme and transporter mediated drug interactions","volume":"1","year":"2020","journal-title":"FDA Guidline"},{"key":"10.1016\/j.ejps.2026.107454_bib0038","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"Vallon","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2026.107454_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101289","article-title":"Recent advances in mass spectrometry-based bioanalytical methods for endogenous biomarkers analysis in transporter-mediated drug-drug interactions","author":"Vo","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ejps.2026.107454_bib0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40005-022-00563-1","article-title":"Effects of 1\u03b1,25-dihydroxyvitamin D3 on the pharmacokinetics and biodistribution of ergothioneine, an endogenous organic cation\/carnitine transporter 1 substrate, in rats","volume":"52","author":"Vo","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejps.2026.107454_bib0041","first-page":"1","article-title":"Impact of 1\u03b1, 25-dihydroxyvitamin D3 on biodistribution and pharmacokinetics of L-carnitine and creatinine, organic cation\/carnitine transporter 2 and organic cation transporter 2 biomarkers","author":"Vo","year":"2024","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejps.2026.107454_bib0042","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40262-021-01004-2","article-title":"Clinical investigation on endogenous biomarkers to predict strong OAT-mediated drug\u2013Drug interactions","volume":"60","author":"Willemin","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107454_bib0043","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1038\/s41598-017-04949-2","article-title":"Key role for the organic anion transporters, OAT1 and OAT3, in the in vivo handling of uremic toxins and solutes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107454_bib0044","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejps.2012.12.024","article-title":"OAT1 and OAT3: targets of drug\u2013drug interaction between entecavir and JBP485","volume":"48","author":"Xu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107454_bib0045","doi-asserted-by":"crossref","first-page":"16998","DOI":"10.1074\/jbc.RA120.013610","article-title":"pH-dependent pyridoxine transport by SLC19A2 and SLC19A3: implications for absorption in acidic microclimates","volume":"295","author":"Yamashiro","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2026.107454_bib0046","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.2042-7158.2010.01213.x","article-title":"Modulated pharmacokinetics and increased small intestinal toxicity of methotrexate in bilirubin-treated rats","volume":"63","author":"Yokooji","year":"2011","journal-title":"J. Pharmacy Pharmacol."},{"key":"10.1016\/j.ejps.2026.107454_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107647","article-title":"Regulation of organic anion transporters: role in physiology, pathophysiology, and drug elimination","volume":"217","author":"Zhang","year":"2021","journal-title":"Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:50:16Z","timestamp":1772491816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872600028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"alternative-id":["S092809872600028X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107454","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcitriol-mediated modulation of organic anion transporters: Insights from endogenous biomarkers and methotrexate pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107454"}}